BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37488608)

  • 1. Radiological evidence of rapid growth acceleration of a small part solid nodule found to be large-cell carcinoma of the lung.
    Lu Y; Sun Z; Li H; Chen X; Li Y; Sun L; Yang F; Jiang G; Zhou J
    J Cardiothorac Surg; 2023 Jul; 18(1):236. PubMed ID: 37488608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer.
    Obayashi K; Shimizu K; Nakazawa S; Nagashima T; Yajima T; Kosaka T; Atsumi J; Kawatani N; Yazawa T; Kaira K; Mogi A; Kuwano H
    J Thorac Dis; 2018 Sep; 10(9):5428-5434. PubMed ID: 30416791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
    Kobayashi Y; Mitsudomi T
    Transl Lung Cancer Res; 2013 Oct; 2(5):354-63. PubMed ID: 25806254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgery for Pulmonary Multiple Ground Glass Opacities].
    Wang Q; Jiang W; Xi J
    Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):355-8. PubMed ID: 27335296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
    AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.
    Shimada Y; Saji H; Otani K; Maehara S; Maeda J; Yoshida K; Kato Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Akata S; Ikeda N
    Lung Cancer; 2015 May; 88(2):174-80. PubMed ID: 25758554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease.
    Gu B; Burt BM; Merritt RE; Stephanie S; Nair V; Hoang CD; Shrager JB
    Ann Thorac Surg; 2013 Aug; 96(2):411-8. PubMed ID: 23806231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
    Zhang Y; Fu F; Chen H
    Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.
    Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R
    Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer-aided three-dimensional volumetry.
    Oda S; Awai K; Murao K; Ozawa A; Utsunomiya D; Yanaga Y; Kawanaka K; Yamashita Y
    Acad Radiol; 2011 Jan; 18(1):63-9. PubMed ID: 21145028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph Node Metastases in Surgically Resected Solitary Ground-Glass Opacities: A Two-Center Retrospective Cohort Study and Pooled Literature Analysis.
    Xu S; He Z; Li X; He J; Ni H; Ren D; Ren F; Li T; Chen G; Chen L; Chen J
    Ann Surg Oncol; 2023 Jun; 30(6):3760-3768. PubMed ID: 36897416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals.
    Heuvelmans MA; Oudkerk M; de Bock GH; de Koning HJ; Xie X; van Ooijen PM; Greuter MJ; de Jong PA; Groen HJ; Vliegenthart R
    Eur Radiol; 2013 Jul; 23(7):1836-45. PubMed ID: 23508275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term course of ground-glass opacities detected on thin-section computed tomography.
    Lee SW; Leem CS; Kim TJ; Lee KW; Chung JH; Jheon S; Lee JH; Lee CT
    Respir Med; 2013 Jun; 107(6):904-10. PubMed ID: 23514949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
    Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
    Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.
    Setojima Y; Shimada Y; Tanaka T; Shigefuku S; Makino Y; Maehara S; Hagiwara M; Masuno R; Yamada T; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):763-770. PubMed ID: 31746987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of lung carcinoma arising from ground glass opacities (GGO) after 5 years - A retrospective review.
    Herskovitz E; Solomides C; Barta J; Evans N; Kane G
    Respir Med; 2022 May; 196():106803. PubMed ID: 35305375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning-assisted nodule segmentation.
    Qi LL; Wu BT; Tang W; Zhou LN; Huang Y; Zhao SJ; Liu L; Li M; Zhang L; Feng SC; Hou DH; Zhou Z; Li XL; Wang YZ; Wu N; Wang JW
    Eur Radiol; 2020 Feb; 30(2):744-755. PubMed ID: 31485837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ground-glass nodule in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK)-positive lung cancer: a case report.
    Owada Y; Yonechi A; Higuchi M; Suzuki H
    World J Surg Oncol; 2016 Mar; 14():81. PubMed ID: 26964537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameter.
    Li W; Zhou F; Wan Z; Li M; Zhang Y; Bao X; Zhang L; Shi J
    Lung Cancer; 2019 Oct; 136():37-44. PubMed ID: 31437662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.
    Lindell RM; Hartman TE; Swensen SJ; Jett JR; Midthun DE; Tazelaar HD; Mandrekar JN
    Radiology; 2007 Feb; 242(2):555-62. PubMed ID: 17255425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.